(Press-News.org) Melbourne researchers are now simulating in 3D, the motion of the complete human rhinovirus, the most frequent cause of the common cold, on Australia's fastest supercomputer, paving the way for new drug development.
Rhinovirus infection is linked to about 70 per cent of all asthma exacerbations with more than 50 per cent of these patients requiring hospitalisation. Furthermore, over 35 per cent of patients with acute chronic obstructive pulmonary disease (COPD) are hospitalised each year due to respiratory viruses including rhinovirus.
A new antiviral drug to treat rhinovirus infections is being developed by Melbourne company Biota Holdings Ltd, targeted for those with these existing conditions where the common cold is a serious threat to their health and could prove fatal.
A team of researchers led by Professor Michael Parker from St Vincent's Institute of Medical Research (SVI) and the University of Melbourne is now using information on how the new drug works to create a 3D simulation of the complete rhinovirus using Australia's fastest supercomputer.
"Our recently published work with Biota shows that the drug binds to the shell that surrounds the virus, called the capsid. But that work doesn't explain in precise detail how the drug and other similar acting compounds work," Professor Parker said.
Professor Parker and his team are working on the newly installed IBM Blue Gene/Q at the University of Melbourne with computational biologists from IBM and the Victorian Life Sciences Computation Initiative (VLSCI).
In production from 1 July 2012, the IBM Blue Gene/Q is the most powerful supercomputer dedicated to life sciences research in the Southern Hemisphere and currently ranked the fastest in Australia.
"The IBM Blue Gene/Q will provide us with extraordinary 3D computer simulations of the whole virus in a time frame not even dreamt of before," Professor Parker said.
"Supercomputer technology enables us to delve deeper in the mechanisms at play inside a human cell, particularly how drugs work at a molecular level.
"This work offers exciting opportunities for speeding up the discovery and development of new antiviral treatments and hopefully save many lives around the world," he said.
Professor Parker said that previously we have only been able to run smaller simulations on just parts of the virus.
Professor James McCluskey Deputy Vice-Chancellor (Research) at the University of Melbourne said: "The work on rhinovirus is an example of how new approaches to treat disease will become possible with the capacity of the IBM Blue Gene Q, exactly how we hoped this extraordinary asset would be utilised by the Victorian research community in collaboration with IBM."
"This is a terrific facility for Victorian life science researchers, further strengthening Victoria's reputation as a leading biotechnology centre," he said.
Dr John Wagner, Manager, IBM Research Collaboratory for Life Sciences-Melbourne, co located at VLSCI, said these types of simulations are the way of the future for drug discovery.
"This is the way we do biology in the 21st Century," he said.
The newly operational IBM Blue Gene/Q hosted by the University of Melbourne at the VLSCI is ranked 31st on the prestigious global TOP500 list. The TOP500 table nominates the 500 most powerful computer systems in the world.
The VLSCI is an initiative of the Victorian Government in partnership with the University of Melbourne and the IBM Life Sciences Research Collaboratory, Melbourne.
INFORMATION:
3-D motion of cold virus offers hope for improved drugs using Australia's fastest supercomputer
2012-07-18
ELSE PRESS RELEASES FROM THIS DATE:
Controlling uncertainty: Why do consumers need to believe in certain service providers?
2012-07-18
Consumers evaluate services and make decisions based on the level of uncertainty associated with a product—the greater the uncertainty, the more likely it is they will need to have faith in a company and focus on its unique offerings, according to a new study in the Journal of Consumer Research.
"Some services can be evaluated with actual experience, whereas other services are difficult to evaluate even with experience—they have to be taken on faith. Services taken on faith are more difficult to evaluate, and are usually perceived to have greater uncertainty and higher ...
Online self-diagnosis: Am I having a heart attack or is it just the hiccups?
2012-07-18
Consumers who self-diagnose are more likely to believe they have a serious illness because they focus on their symptoms rather than the likelihood of a particular disease, according to a new study in the Journal of Consumer Research. This has significant implications for public health professionals as well as consumers.
"In today's wired world, self-diagnosis via internet search is very common. Such symptom-matching exercises may lead consumers to overestimate the likelihood of getting a serious disease because they focus on their symptoms while ignoring the very low ...
UCSB study reveals brain functions during visual searches
2012-07-18
(Santa Barbara, Calif.) –– You're headed out the door and you realize you don't have your car keys. After a few minutes of rifling through pockets, checking the seat cushions and scanning the coffee table, you find the familiar key ring and off you go. Easy enough, right? What you might not know is that the task that took you a couple seconds to complete is a task that computers –– despite decades of advancement and intricate calculations –– still can't perform as efficiently as humans: the visual search.
"Our daily lives are comprised of little searches that are constantly ...
Glacier break creates ice island 2 times the size of Manhattan
2012-07-18
An ice island twice the size of Manhattan has broken off from Greenland's Petermann Glacier, according to researchers at the University of Delaware and the Canadian Ice Service. The Petermann Glacier is one of the two largest glaciers left in Greenland connecting the great Greenland ice sheet with the ocean via a floating ice shelf.
Andreas Muenchow, associate professor of physical ocean science and engineering in UD's College of Earth, Ocean, and Environment, reports the calving on July 16, 2012, in his "Icy Seas" blog. Muenchow credits Trudy Wohleben of the Canadian ...
Mothers who give birth to large infants at increased risk for breast cancer
2012-07-18
Delivering a high-birth-weight infant more than doubles a woman's breast cancer risk, according to research from the University of Texas Medical Branch at Galveston. The researchers suggest that having a large infant is associated with a hormonal environment during pregnancy that favors future breast cancer development and progression.
Marking the first time that high birth weight was shown to be an independent risk factor, the finding may help improve prediction and prevention of breast cancer decades before its onset.
"We also found that women delivering large babies ...
Study identifies how muscles are paralyzed during sleep
2012-07-18
Washington, D.C. — Two powerful brain chemical systems work together to paralyze skeletal muscles during rapid eye movement (REM) sleep, according to new research in the July 18 issue of The Journal of Neuroscience. The finding may help scientists better understand and treat sleep disorders, including narcolepsy, tooth grinding, and REM sleep behavior disorder.
During REM sleep — the deep sleep where most recalled dreams occur — muscles that move the eyes and those involved in breathing continue to move, but the most of the body’s other muscles are stopped, potentially ...
A nursing program shows promise for reducing deaths from chronic illnesses
2012-07-18
A community-based nursing program delivered in collaboration with existing health care services is more effective in reducing the number of older people dying from chronic illnesses, such as cardiovascular disease and diabetes, than usual care according to a study by US researchers published in this week's PLoS Medicine.
The authors led by Kenneth Coburn from Health Quality Partners in Pennsylvania in the US, randomized 1736 eligible patients (aged 65 years and over with heart failure, coronary heart disease, asthma, diabetes, hypertension, and/or hyperlipidemia who received ...
Reporting of hospital infection rates and burden of C. difficile
2012-07-18
A new study published today in PLoS Medicine re-evaluates the role of public reporting of hospital-acquired infection data. The study, conducted by Nick Daneman and colleagues, used data from all 180 acute care hospitals in Ontario, Canada. The investigators compared the rates of infection of Clostridium difficile colitis prior to, and after, the introduction of public reporting of hospital performance; public reporting was associated with a 26% reduction in C. difficile cases.
The authors comment "This longitudinal population-based cohort study has confirmed an immense ...
Social entrepreneurship for sexual health
2012-07-18
In this week's PLoS Medicine, Joseph Tucker from the University of North Carolina, Chapel Hill, North Carolina, USA and colleagues lay out a social entrepreneurship for sexual health (SESH) approach that focuses on decentralized community delivery, multisectoral networks, and horizontal collaboration (business, technology, and academia).
They argue that while SESH approaches have yet to be widely implemented, they show great promise: "Social marketing and sales of point-of-care, community-based tests for HIV and other sexually transmitted diseases, conditional cash transfers ...
Trials involving switching HIV drugs may not be beneficial to participants
2012-07-18
A increasingly used type of HIV study which involves switching patients on one type of antiretroviral therapy (ART) to another, to see whether the new drug is as good as the at preventing replication of the HIV virus, may be unethical, according to a new Essay published in this week's PLoS Medicine. The studies, termed non-inferiority trials, are only ethical if participants can meaningfully benefit from the treatment change and are more likely to benefit than suffer harm, according to Andrew Carr from the HIV unit in St Vincent's Hospital in Sydney, Australia, Jennifer ...